NEW BPC-157, TB-500 and four more now allowed to be compounded

Peptide Therapy

Physician-guided peptide therapy

Peptides are small proteins that act as messengers in the body. After a full consultation, Dr. Verma may prescribe peptides prepared by licensed U.S. 503A compounding pharmacies for goals such as recovery, sleep, metabolism, focus, sexual health and skin.

Prescribed by

Dr. Sagar Verma, MD, after a consultation

Prepared by

Licensed U.S. 503A compounding pharmacies

Where

Warrenton, Culpeper and Fairfax

Staying current

Six more peptides now allowed to be compounded

In July 2026, an FDA advisory committee voted in favor of six peptides. In October 2026, the federal government cleared the way for licensed U.S. compounding pharmacies to prepare them for patients with a doctor’s prescription.

That means you no longer need to turn to “research-only” products sold online. Dr. Verma prescribes these peptides only through licensed U.S. pharmacies that use tested, registered ingredient sources.

We also prescribe other compounded peptides, such as AOD-9604, thymosin alpha-1 and LL-37. These are not part of the October 2026 policy. Learn more about them.

BPC-157
Recovery

TB-500
Recovery and flexibility

MOTS-c
Energy and metabolism

Epitalon
Healthy aging and sleep

Semax
Focus and mental energy

KPV
Gut and skin calm

The basics

What are peptides?

“Peptides get a lot of hype. I prescribe only peptides prepared by licensed U.S. pharmacies, and I will always tell you honestly what the evidence does and does not show.”

Dr. Sagar Verma, MD
Founder and Medical Director

Peptides are short chains of amino acids, the building blocks of protein. Your body makes thousands of them, and many act as signals that tell cells what to do, from releasing hormones to repairing tissue.

Some well-known medicines are peptides, including insulin and the GLP-1 weight loss medicines semaglutide and tirzepatide. Other peptides are prepared by compounding pharmacies, which make medicines for an individual patient based on a prescription.

There is a lot of misleading information about peptides online. Many products sold online are labeled “for research only” and are not made for people. We prescribe only through licensed U.S. pharmacies.

Now available

Recovery, energy and healthy-aging peptides

Each is prepared by a licensed U.S. compounding pharmacy from tested ingredients.

Recovery

BPC-157Body Protection Compound-157

Injection · oral

What it is A 15-amino-acid peptide based on a protective protein found naturally in stomach juice. It has been studied for more than 30 years.

How it works Animal research suggests it may help grow new small blood vessels into injured tissue, support the growth signals that repair tendons and ligaments, and protect the lining of the gut.

Goals it may support Recovery of tendons, ligaments, muscles and joints, recovery after hard training, and a healthy gut lining.

What the evidence shows Most of the research comes from animal studies, much of it from Croatia over 30 years. Human data are limited to small, uncontrolled reports.

How it is given A small injection under the skin, often near the area of concern, usually daily for 4 to 8 weeks. An oral capsule may be used for gut goals.

Possible side effects Usually mild: redness or irritation where injected. Some people report brief nausea, dizziness or headache.

May not be right for you if You are pregnant or breastfeeding, or have an active cancer or recent history of cancer.

  1. ReviewSikiric et al., Current Pharmaceutical Design, 2011. Protective effects on the digestive tract, almost entirely from animal work. Croatia.
  2. ReviewSeiwerth et al., Frontiers in Pharmacology, 2021. Wound healing across skin and other tissues, mainly from rodent studies. Croatia.
  3. Systematic reviewVasireddi et al., HSS Journal, 2025. 36 studies on muscles, tendons and bones (35 animal, 1 human); human safety data still limited. USA.
  4. Human studyLee et al., Alternative Therapies in Health and Medicine, 2021. 17 patients with knee pain given injections; most reported improvement (no control group). USA.
  5. ReviewJózwiak et al., Pharmaceuticals, 2025. Preclinical findings, proposed mechanisms and safety questions. Poland.

Recovery and flexibility

TB-500a short active piece of thymosin beta-4

Injection

What it is A synthetic copy of the active region of thymosin beta-4, a repair protein found in nearly every cell in the body.

How it works In research, thymosin beta-4 appears to help repair cells move to where they are needed, support new blood vessel growth and calm inflammation. TB-500 is thought to act in a similar way.

Goals it may support Recovery of muscles, tendons and ligaments, flexibility, and recovery after hard training. It is often prescribed alongside BPC-157.

What the evidence shows Human trials have used the full thymosin beta-4 protein, for eyes, wounds and the heart. TB-500 itself has not been tested in published human trials.

How it is given A small injection under the skin or into the muscle, usually once or twice a week for 4 to 6 weeks, then less often.

Possible side effects Redness where injected, and occasionally brief tiredness or headache.

May not be right for you if You are pregnant or breastfeeding, or have an active cancer or recent history of cancer.

  1. Lab studyEsposito et al., Manfred Donike Workshop proceedings, 2012. Identified TB-500 as a short fragment of thymosin beta-4. Belgium.
  2. Clinical trialSosne & Ousler, Clinical Ophthalmology, 2015. Full thymosin beta-4 eye drops in 72 people with dry eye; some measures favored treatment. USA.
  3. Clinical trialEudraCT 2005-004500-37 (Sigma-Tau). Phase II trial of thymosin beta-4 gel for venous leg ulcers. Italy.
  4. Animal studyHinkel et al., Journal of Molecular and Cellular Cardiology, 2015. Thymosin beta-4 fragments after heart injury in mice and pigs. Germany, USA, Hungary.
  5. Lab and animal studyRahaman et al., Journal of Chromatography B, 2024. How TB-500 breaks down in the body; one breakdown product showed wound-healing activity. South Korea.

Energy and metabolism

MOTS-ca messenger peptide made by your mitochondria

Injection

What it is A 16-amino-acid peptide coded in the DNA of mitochondria, the energy centers of your cells. It carries signals from the mitochondria to the rest of the body, and levels tend to fall with age.

How it works Research suggests it activates AMPK, the cell’s main energy sensor, which may help muscles use sugar and fat for fuel. Exercise turns on the same pathway.

Goals it may support Energy and stamina, exercise endurance, healthy blood sugar balance, body composition and healthy aging.

What the evidence shows In people, MOTS-c levels rise with exercise and may be lower in diabetes. Treatment studies so far are in animals.

How it is given A small injection under the skin a few times a week for a 4- to 8-week course, ideally alongside regular exercise.

Possible side effects Redness where injected and brief tiredness. Blood sugar may drop in people who take diabetes medicines.

May not be right for you if You are pregnant or breastfeeding. If you take insulin or other blood sugar medicines, we monitor you closely.

  1. Human and animal studyReynolds et al., Nature Communications, 2021. MOTS-c rises with exercise in people; in older mice it improved physical performance. USA and international.
  2. Human studyZempo et al., Aging, 2021. In about 27,500 people, a MOTS-c gene variant was linked to type 2 diabetes in less active men. Japan and USA.
  3. Meta-analysisZhou et al., Diabetology & Metabolic Syndrome, 2024. Blood MOTS-c tended to be lower in people with diabetes. China.
  4. ReviewMohtashami et al., International Journal of Molecular Sciences, 2022. MOTS-c in human aging; evidence mostly animal and association data. USA.

Healthy aging and sleep

Epitalona 4-amino-acid pineal peptide

Injection · short courses

What it is A very short peptide (alanine, glutamic acid, aspartic acid and glycine), made to match the active part of a natural extract of the pineal gland, the small gland that sets your sleep–wake rhythm.

How it works It may help the pineal gland keep a healthy nighttime melatonin rhythm. In lab studies, it activated telomerase, the enzyme that protects the ends of chromosomes (telomeres) as cells age.

Goals it may support Sleep rhythm, especially with aging, jet lag or shift work; antioxidant protection; and healthy aging.

What the evidence shows It has been studied for decades, including long-term studies in older adults using a related pineal extract. Larger controlled human trials are still needed.

How it is given A small injection under the skin daily for 10 to 20 days, repeated once or twice a year. It is not used continuously.

Possible side effects Few side effects have been reported. Mild redness where injected.

May not be right for you if You are pregnant or breastfeeding, or have an active cancer or recent history of cancer.

  1. Human studyKhavinson et al., Neuro Endocrinology Letters, 2003. Older adults given pineal and thymus peptide extracts over 6 to 8 years had fewer age-related illnesses (used the parent extract, Epithalamin). Russia.
  2. Human studyKorkushko et al., Innovation in Aging, 2017. In older adults with angina, pineal peptides raised nighttime melatonin. Ukraine and Russia.
  3. Animal studyAnisimov et al., Biogerontology, 2003. In mice, slowed some markers of aging and lengthened maximum lifespan. Russia.
  4. Lab studyAl-dulaimi et al., Biogerontology, 2025. Lengthened telomeres in lab-grown human cells. United Kingdom.
  5. ReviewAraj et al., International Journal of Molecular Sciences, 2025. 25 years of Epitalon research; mechanisms still being studied.

Focus and mental energy

Semaxa 7-amino-acid brain peptide

Nasal spray · injection

What it is A short peptide based on a fragment of ACTH, a natural brain hormone, with a small added tail that helps it last longer. It does not act as a stress hormone.

How it works It may raise BDNF, a growth factor that helps nerve cells grow, connect and learn, and it may help balance dopamine and serotonin.

Goals it may support Focus, memory, mental energy, mental clarity and resilience during stress.

What the evidence shows Studied for decades, mostly in recovery after stroke. Most studies are small or in animals.

How it is given A nasal spray or a small injection under the skin, usually once or twice a day for a 2- to 4-week course. It is best taken in the morning.

Possible side effects Nasal irritation, restlessness, or trouble sleeping if taken late in the day.

May not be right for you if You are pregnant or breastfeeding, have a history of seizures, or have bipolar disorder or severe anxiety.

  1. Human studyGusev et al., Neurology Bulletin, 1997. After stroke, movement recovery may have been faster with Semax. Russia.
  2. ReviewDergunova et al., Genes, 2023. Brain-protective peptides studied after stroke, including Semax. Russia.
  3. Animal studyDmitrieva et al., Cellular and Molecular Neurobiology, 2010. Increased brain growth factor genes after stroke in rats. Russia.
  4. Animal studyMedvedeva et al., BMC Genomics, 2014. Changed immune and blood-vessel genes after stroke in rats. Russia.

Gut and skin calm

KPVlysine–proline–valine, a 3-amino-acid peptide

Oral · topical cream

What it is A tiny peptide taken from the tail end of alpha-MSH, a natural anti-inflammatory hormone. Unlike alpha-MSH, it does not darken the skin.

How it works Lab research suggests it may enter cells in the gut lining and skin and quiet NF-κB, a main switch for inflammation.

Goals it may support A calm, comfortable gut and a healthy gut lining, and calm, comfortable skin.

What the evidence shows Studied in animal and lab models of gut inflammation. It has not yet been tested in human trials.

How it is given By mouth daily for gut goals, or as a cream applied to the skin. KPV is not given by injection.

Possible side effects Mild stomach upset by mouth; mild irritation with the cream.

May not be right for you if You are pregnant or breastfeeding, or have a known allergy to peptide products.

  1. Animal studyKannengiesser et al., Inflammatory Bowel Diseases, 2008. Reduced colon inflammation and sped recovery in mice. Germany.
  2. Animal studyXiao et al., Molecular Therapy, 2017. Oral KPV particles targeted to the colon lessened colitis in mice. USA and China.
  3. ReviewBrzoska et al., Endocrine Reviews, 2008. Much of alpha-MSH’s anti-inflammatory activity comes from its KPV tail. Germany.
  4. ReviewGravina et al., Cells, 2023. The melanocortin system in inflammatory bowel disease. Italy.

Compounded peptides are not FDA-approved, and some uses described here are off-label. Results vary. Your plan is set after your consultation and may include labs before and during treatment.

What we offer

More peptides we may prescribe

Every prescription follows a consultation, and your plan is based on your health history, goals and, when needed, lab results.

Sexual health

PT-141bremelanotide

Injection · nasal spray

What it is A synthetic peptide related to a natural brain hormone (alpha-MSH). It is FDA-approved, as the brand Vyleesi, for premenopausal women with low sexual desire that causes distress. Use in men and in postmenopausal women is off-label.

How it works It is thought to act on melanocortin receptors in the parts of the brain involved in desire and arousal. This is different from Viagra-type medicines, which work on blood flow.

Goals it may support Sexual desire and arousal in women and men.

What the evidence shows Two large phase 3 trials in 1,267 women found improved desire and less distress compared with placebo. Smaller studies in men found a better erection response than placebo.

How it is given A small injection under the skin about 45 minutes before intimacy, only as needed and not more than once in 24 hours. A nasal spray may also be available.

Possible side effects Nausea (common, especially with the first doses), flushing and headache. Blood pressure can rise briefly after a dose. With frequent use, some people notice darker spots on the skin.

May not be right for you if You are pregnant, have uncontrolled high blood pressure or heart disease, or take naltrexone.

  1. FDA labelVYLEESI Prescribing Information, U.S. FDA. FDA-approved for low sexual desire in premenopausal women. USA.
  2. Clinical trialKingsberg et al., Obstetrics & Gynecology, 2019. RECONNECT trials, 1,267 women: improved desire and reduced distress versus placebo. USA.
  3. Human studyDiamond et al., International Journal of Impotence Research, 2004. In men, nasal PT-141 may help produce erections versus placebo. USA.

Sexual health

Oxytocinthe “bonding hormone”

Nasal spray · dissolving tablet

What it is A natural hormone made in the brain and released during touch, intimacy, orgasm and breastfeeding. An FDA-approved injectable form is used in childbirth; use for sexual health is off-label.

How it works It is thought to act on brain areas linked to trust, closeness and pleasure, and may help the body relax into intimacy.

Goals it may support Emotional closeness, arousal, orgasm and satisfaction, for women and men.

What the evidence shows Small studies in Austria and Germany suggest it may improve orgasm intensity and contentment after sex. In one trial, couples on placebo also improved, which suggests better communication plays a big role too.

How it is given A nasal spray or a tablet that dissolves under the tongue, shortly before intimacy.

Possible side effects Mild headache or nasal irritation.

May not be right for you if You are pregnant.

  1. Clinical trialMuin et al., Fertility and Sterility, 2015. 8-month trial in women: oxytocin and placebo both improved sex life, suggesting communication matters too. Austria.
  2. Human studyBehnia et al., Hormones and Behavior, 2014. In 29 couples, may have increased orgasm intensity and contentment. Germany.
  3. Human studyKruger et al., Journal of Clinical Psychopharmacology, 2018. In 27 women, a single dose did not clearly change sexual response in a lab setting. Germany.

Sleep and recovery

Sermorelinthe first 29 amino acids of your body’s growth hormone–releasing hormone (GHRH)

Injection

What it is The active portion of GHRH, the natural signal your brain uses to tell the pituitary gland to release growth hormone. It was once FDA-approved as the brand Geref for children with growth hormone deficiency; that brand was later discontinued by its maker.

How it works Instead of replacing growth hormone, it is designed to prompt your own pituitary to release it in natural pulses, working through your body’s normal feedback system.

Goals it may support Sleep quality, recovery after exercise, energy and body composition, often alongside hormone therapy.

What the evidence shows In an NIH study, older men who used it for two weeks had growth hormone and IGF-1 levels move closer to those of younger men. In a 5-month study of adults aged 55 to 71, levels rose, and men may have gained lean muscle and reported better well-being.

How it is given A small injection under the skin at bedtime, most nights of the week, with IGF-1 blood tests to guide the dose.

Possible side effects Redness or soreness where injected, flushing and headache. Some people notice vivid dreams or mild water retention.

May not be right for you if You are pregnant or breastfeeding, have an active cancer, or have untreated thyroid disease or uncontrolled diabetes.

  1. Clinical trialCorpas et al., Journal of Clinical Endocrinology & Metabolism, 1992. In older men, raised growth hormone and IGF-1 toward younger levels. USA (NIH).
  2. Clinical trialKhorram et al., Journal of Clinical Endocrinology & Metabolism, 1997. 5 months in adults 55 to 71: raised GH and IGF-1; men may have gained lean mass. USA.

Skin and hair

GHK-Cucopper peptide

Topical serum · scalp

What it is A tiny natural peptide (glycine, histidine and lysine) bound to copper. It is found in blood and saliva, and levels drop considerably as we age.

How it works It appears to signal skin cells to build collagen and elastin, support wound repair and calm oxidative stress. Lab studies suggest it switches on many genes involved in tissue repair.

Goals it may support Skin firmness, fine lines, texture and tone, and skin recovery after microneedling or laser treatments. On the scalp, it may support thicker-looking hair.

What the evidence shows Lab research and small cosmetic studies with creams suggest improvements in fine lines and firmness. Because it does not pass through skin easily, it is often paired with microneedling to help it absorb.

How it is given A serum or cream applied to the face or scalp, often right after a microneedling, Vampire Facial® or laser session in our office, then continued at home.

Possible side effects Mild redness, tingling or irritation where applied.

May not be right for you if You have a copper allergy or Wilson disease, or you are pregnant or breastfeeding.

  1. ReviewPickart et al., BioMed Research International, 2015. How GHK, which declines with age, may support skin repair and collagen. USA.
  2. ReviewPickart et al., International Journal of Molecular Sciences, 2018. Tissue-repair and protective effects of GHK-Cu. USA.
  3. ReviewMortazavi et al., BioImpacts, 2024. GHK for wrinkles, and delivery methods such as microneedling. Iran.

Weight and metabolism

GLP-1 medicinessemaglutide (Wegovy®) and tirzepatide (Zepbound®)

Weekly injection

What it is Peptide medicines that copy natural gut hormones released after you eat. Semaglutide copies GLP-1. Tirzepatide copies both GLP-1 and GIP. Both are FDA-approved for chronic weight management.

How it works They slow how quickly the stomach empties, help you feel full sooner and longer, quiet constant thoughts about food, and help insulin respond to meals.

Goals it may support Weight management and healthy blood sugar as part of a medical weight loss program. Wegovy is also FDA-approved to lower the risk of heart attack and stroke in certain adults with heart disease, and Zepbound for obstructive sleep apnea in certain adults with obesity.

What the evidence shows In the STEP 1 trial, adults on semaglutide lost about 15% of their body weight on average over 68 weeks, compared with about 2% on placebo. In SURMOUNT-1, adults on tirzepatide lost about 15% to 21% over 72 weeks, compared with about 3% on placebo.

How it is given A once-weekly injection under the skin. The dose starts low and rises slowly over several months to limit stomach side effects. We prescribe FDA-approved brands as part of our medical weight loss program, with nutrition support and labs.

Possible side effects Nausea, constipation, diarrhea or reflux, mostly when the dose goes up. Less often, gallbladder problems or pancreatitis.

May not be right for you if You or a family member has had medullary thyroid cancer or MEN2, you have had pancreatitis, or you are pregnant or trying to conceive.

  1. Clinical trialWilding et al. (STEP 1), New England Journal of Medicine, 2021. Semaglutide: about 15% average weight loss at 68 weeks versus 2.4% with placebo. UK-led, international.
  2. Clinical trialJastreboff et al. (SURMOUNT-1), New England Journal of Medicine, 2022. Tirzepatide: about 15% to 21% average weight loss at 72 weeks. USA-led, international.
  3. FDA labelZEPBOUND Prescribing Information, DailyMed. Official FDA label for tirzepatide. USA.
  4. FDA labelWEGOVY Prescribing Information, U.S. FDA. Official FDA label for semaglutide. USA.

Whole-person care

Your personal plan

Peptides work best alongside sleep, nutrition, exercise and, when needed, hormone care. We build them into a complete plan.

PT-141 (Vyleesi®) and the GLP-1 medicines are FDA-approved for specific uses; uses outside those approvals are off-label. Compounded peptides, including compounded versions of these medicines, are not FDA-approved.

Other compounded therapies

Metabolic and cellular-energy support

These are prepared by licensed U.S. compounding pharmacies and prescribed after a consultation.

Belly fat and body composition

TesamorelinA growth hormone–releasing peptide; the active ingredient in an FDA-approved medicine

Injection

What it is A 44-amino-acid version of GHRH, the brain’s natural signal for growth hormone release. It is the active ingredient in Egrifta, which is FDA-approved to reduce excess abdominal fat in adults with HIV-related lipodystrophy. Our compounded form is not FDA-approved.

How it works It prompts the pituitary to release your own growth hormone, which may help the body reduce deep belly fat around the organs.

Goals it may support Reducing deep abdominal (visceral) fat and healthier body composition, alongside nutrition and exercise. Use outside its FDA-approved indication is off-label.

What the evidence shows Strong trial evidence for reducing deep belly fat in people with HIV, and promising studies in abdominal obesity without HIV.

How it is given A small daily injection under the skin, usually at bedtime, for a set course with lab monitoring.

Possible side effects Joint aches, swelling, redness where injected, and numbness or tingling in the hands. It can raise blood sugar in some people.

May not be right for you if You are pregnant or breastfeeding, have an active cancer, or have a pituitary condition. If you have diabetes, we monitor blood sugar closely.

  1. FDA labelEGRIFTA SV Prescribing Information, U.S. FDA. FDA-approved to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. USA.
  2. Clinical trialFalutz et al., Journal of Clinical Endocrinology & Metabolism, 2010. Two phase 3 trials, 806 patients: reduced visceral fat, maintained through 52 weeks. Canada, multinational.
  3. Clinical trialStanley et al., JAMA, 2014. Six months reduced visceral fat and modestly reduced liver fat. USA.
  4. Clinical trialMakimura et al., Journal of Clinical Endocrinology & Metabolism, 2012. In 60 adults with abdominal obesity (without HIV), less visceral fat and better triglycerides. USA.

Cellular energy

NAD+A natural coenzyme (not a peptide) every cell uses to make energy; levels fall with age

Injection · IV

What it is Nicotinamide adenine dinucleotide, a helper molecule every cell needs to turn food into energy and to repair DNA. It is not a peptide.

How it works Raising NAD+ may support mitochondria, the cell’s energy centers, and sirtuins, enzymes linked to cell repair and healthy aging.

Goals it may support Energy, mental clarity and healthy aging, especially as part of a longevity plan.

What the evidence shows Trials of oral NAD+ building blocks show they raise NAD+ safely. Research on injected and IV NAD+ is still small.

How it is given A small injection under the skin a few times a week, or a slow IV infusion in our office.

Possible side effects Flushing, nausea, chest or stomach tightness and cramping, especially if an IV runs too fast. Redness where injected.

May not be right for you if You are pregnant or breastfeeding.

  1. Human studyGrant et al., Frontiers in Aging Neuroscience, 2019. Pilot study of a 6-hour NAD+ IV infusion. Australia and USA.
  2. Clinical trialMartens et al., Nature Communications, 2018. An oral NAD+ precursor raised NAD+ and was well tolerated in older adults. USA.
  3. Clinical trialOkabe et al., Frontiers in Nutrition, 2022. 12 weeks of oral NMN raised blood NAD+ safely. Japan.
  4. Clinical trialIgarashi et al., npj Aging, 2022. In men 65+, NMN raised NAD+ with possible small gains in walking speed and grip. Japan.

How we choose

Licensed pharmacies only

Every compounded therapy we prescribe is prepared by a licensed U.S. compounding pharmacy for you by name and shipped directly to you. We never use products sold “for research only.”

About these therapies. Compounded tesamorelin and NAD+ are prepared by a licensed pharmacy for an individual patient and are not FDA-approved. The FDA has not reviewed compounded versions for safety, effectiveness or quality. Use of tesamorelin outside its FDA-approved indication is off-label. Individual results vary and are not guaranteed.

Additional compounded peptides

Sleep, immune, hormone and metabolic therapies

These peptides are not FDA-approved. They are prepared by compounding pharmacies on Dr. Verma’s prescription, after a consultation. Please read the note at the end of this section.

Fat metabolism

AOD-9604A modified piece of human growth hormone (amino acids 176–191)

Injection

What it is A 16-amino-acid fragment taken from the tail end of the growth hormone molecule, with one small change that makes it more stable. It was developed in Australia in the 1990s as a possible weight-loss medicine.

How it works It appears to copy the part of growth hormone that helps the body break down stored fat and may slow the build-up of new fat. Unlike full growth hormone, it does not act on the main growth hormone receptor. In human safety studies it did not raise IGF-1 or blood sugar.

Goals it may support Fat loss, especially around the waist, and body composition, as part of a nutrition and exercise plan.

What the evidence shows Early human trials suggested modest weight loss. A larger trial did not show a clear benefit over placebo, so it was not brought to market as an obesity drug. It is not FDA-approved.

How it is given A small daily injection under the skin, usually in the morning before eating.

Possible side effects Usually mild: redness where injected or headache.

May not be right for you if You are pregnant or breastfeeding, or have an active cancer.

  1. Human trialsStier et al., Journal of Endocrinology and Metabolism, 2013. Pooled safety data from six placebo-controlled trials in about 900 adults; tolerated about as well as placebo, with no change in IGF-1 or blood sugar. Germany and Australia.
  2. Animal studyNg et al., Hormone Research, 2000. In obese rats, linked with less weight gain and more fat breakdown. Australia.
  3. Animal studyHeffernan et al., International Journal of Obesity, 2001. In obese mice, reduced weight gain without raising blood sugar. Australia.
  4. ReviewDominikowski et al., Frontiers in Endocrinology, 2026. Notes that human data are limited and short-term. Poland.

Growth hormone support

CJC-1295a long-acting growth hormone–releasing peptide

Injection

What it is A modified version of GHRH, your brain’s natural signal to release growth hormone, built to last longer than natural GHRH or sermorelin. It comes in two forms: with DAC, which lasts several days, and without DAC (also called Mod GRF 1-29), which lasts about half an hour.

How it works It tells the pituitary gland to release your own growth hormone. Paired with ipamorelin, which works on a different receptor, it may produce a stronger but still natural pulse.

Goals it may support Deeper sleep, recovery, lean muscle, fat loss, energy, and skin and hair quality.

What the evidence shows It raises growth hormone and IGF-1 in healthy adults. Benefits for sleep or body composition have not yet been shown in controlled trials.

How it is given A small injection under the skin, at bedtime for the short-acting form or once or twice a week for the long-acting form, with IGF-1 blood tests.

Possible side effects Flushing or a warm rush after the injection, redness where injected, mild water retention and tingling in the hands.

May not be right for you if You are pregnant or breastfeeding, have an active cancer, or have uncontrolled diabetes.

  1. Clinical trialTeichman et al., Journal of Clinical Endocrinology & Metabolism, 2006. In healthy adults, injections produced longer-lasting rises in growth hormone and IGF-1, with no serious side effects. USA and Canada.
  2. Human studyIonescu et al., Journal of Clinical Endocrinology & Metabolism, 2006. Raised growth hormone while keeping the body’s natural pulse pattern. USA.
  3. Animal studyJetté et al., Endocrinology, 2005. Original development work showing a long-acting effect. Canada.
  4. ReviewDominikowski et al., Frontiers in Endocrinology, 2026. Early safety and hormone data in adults; real-world benefit not yet shown in controlled studies. Poland.

Sleep and recovery

Ipamorelina 5-amino-acid growth hormone secretagogue

Injection

What it is A small peptide that acts on the ghrelin receptor in the pituitary gland to trigger a short pulse of growth hormone. It was developed in Denmark in the 1990s.

How it works Unlike older peptides in its class, it has little effect on cortisol, prolactin or appetite in studies, which may give a cleaner growth hormone pulse. It is often combined with CJC-1295.

Goals it may support Sleep depth, recovery, lean muscle, fat loss, energy, and skin and hair quality.

What the evidence shows It raises growth hormone in healthy adults. A trial after bowel surgery found it well tolerated but not effective for that use.

How it is given A small injection under the skin at bedtime, usually 5 nights a week in 8- to 12-week cycles, with IGF-1 blood tests.

Possible side effects Redness where injected, headache, flushing, mild water retention and slight hunger.

May not be right for you if You are pregnant or breastfeeding, have an active cancer, or have uncontrolled diabetes.

  1. Animal and lab studyRaun et al., European Journal of Endocrinology, 1998. Original description: released growth hormone without raising stress hormones. Denmark.
  2. Human studyGobburu et al., Pharmaceutical Research, 1999. In healthy men, a short burst of growth hormone with a half-life of about 2 hours. USA.
  3. Clinical trialBeck et al., International Journal of Colorectal Disease, 2014. In 114 patients after bowel surgery, well tolerated; did not speed bowel recovery versus placebo. USA.
  4. ReviewSinha et al., Translational Andrology and Urology, 2020. Growth hormone secretagogues for body composition in men; human data limited. USA.

Immune support

Thymosin alpha-1A 28-amino-acid peptide made by the thymus, the gland that trains immune cells

Injection

What it is A natural thymus peptide first isolated in 1977. Its synthetic form, thymalfasin (brand name Zadaxin), has been sold as a prescription medicine in a number of countries outside the U.S., mainly for chronic hepatitis B. No thymosin alpha-1 product is FDA-approved in the U.S.

How it works It appears to help T cells mature, activate natural killer cells and dendritic cells, and balance immune signaling, which may help the immune system respond in a balanced way.

Goals it may support Immune resilience and recovery after illness, especially when the immune system is run down or aging.

What the evidence shows It has been studied for decades, mostly in Italy and China, in hepatitis B, sepsis, cancer care and as a vaccine helper. Results are mixed: a review of hepatitis B trials found the evidence uncertain, and a large 2025 trial in more than 1,000 patients with sepsis did not find that it lowered the risk of death. Most side effects reported were mild injection-site reactions.

How it is given A small injection under the skin, usually twice a week for a set course.

Possible side effects Usually mild: redness or discomfort where injected.

May not be right for you if You are pregnant or breastfeeding, have had an organ transplant, or take medicines that suppress the immune system.

  1. Clinical trialWu et al. (TESTS), BMJ, 2025. In 1,106 adults with sepsis at 22 hospitals, did not lower 28-day mortality versus placebo. China.
  2. Clinical trialChien et al., Hepatology, 1998. In 98 people with chronic hepatitis B, treated patients appeared more likely to clear viral markers. Taiwan.
  3. ReviewCostantini et al., Frontiers in Oncology, 2019. History of thymosin alpha-1 in cancer care and immune support. Italy and USA.
  4. U.S. trial protocolErshler (PI), ClinicalTrials.gov NCT04428008, 2020. Pilot trial at Inova Fairfax Hospital in older adults on dialysis. USA (Virginia).

Hormone signaling

Kisspeptinthe master switch of the reproductive hormone system

Injection

What it is A natural peptide made in the hypothalamus of the brain. It starts the chain of signals (GnRH, then LH and FSH) that tells the testes and ovaries to make testosterone and estrogen, release eggs and make sperm.

How it works It is designed to prompt your body’s own reproductive hormone signaling rather than replacing hormones.

Goals it may support Healthy sexual desire in men and women, the body’s own hormone signaling for testosterone and estrogen, cycle and fertility goals, and mood and emotional connection.

What the evidence shows Well studied in UK hormone research, where it reliably raises reproductive hormones. Brain-imaging studies also suggest it may strengthen responses to sexual and romantic cues in people with low desire. Its use for libido is still experimental.

How it is given A small injection under the skin, either a few times a week or before intimacy, with hormone blood tests.

Possible side effects Generally well tolerated in studies. Mild flushing or redness where injected.

May not be right for you if You are pregnant or breastfeeding, or have a hormone-sensitive cancer.

  1. Human studyJayasena et al., Human Reproduction, 2015. In healthy men, raised the reproductive hormones LH and FSH. United Kingdom.
  2. Clinical trialMills et al., eBioMedicine, 2025. Nasal kisspeptin raised LH and FSH in men and women, with no side effects reported. United Kingdom.
  3. Human studyJayasena et al., Journal of Clinical Endocrinology & Metabolism, 2013. Twice-daily injections in women; cycles continued normally. United Kingdom.
  4. Human studyChan et al., Journal of Clinical Endocrinology & Metabolism, 2012. Hormone response depended on menstrual cycle phase. USA.
  5. ReviewKotanidou et al., Journal of Clinical Medicine, 2025. Kisspeptin in fertility; uses still experimental. Greece.

Calm and stress resilience

Selanka 7-amino-acid calming peptide

Injection

What it is A synthetic version of tuftsin, a natural immune peptide, with a small added tail that helps it last longer.

How it works It appears to support the brain’s main calming system (GABA) and help balance serotonin and dopamine. It may also influence BDNF and immune signaling.

Goals it may support A calmer response to everyday stress, calm focus without drowsiness, a quieter mind at bedtime, and steady mood.

What the evidence shows A small study in adults with anxiety reported lower anxiety scores.

How it is given A small injection under the skin, usually daily for a 2- to 4-week course.

Possible side effects Mild tiredness and redness where injected.

May not be right for you if You are pregnant or breastfeeding, or take sedating medicines; we review everything you take.

  1. Human studySyunyakov et al., European Psychiatry, 2012. In 20 adults with generalized anxiety, anxiety scores fell within days to two weeks. Russia.
  2. Animal studyVolkova et al., Frontiers in Pharmacology, 2016. Changed calming (GABA-related) gene activity in rats. Russia.
  3. Lab studyFilatova et al., Frontiers in Pharmacology, 2017. Changed how human nerve-type cells responded to GABA. Russia.
  4. Animal studyKolik et al., Bulletin of Experimental Biology and Medicine, 2014. Reduced anxiety-like behavior in rats during alcohol withdrawal. Russia.

Deep sleep

DSIPdelta sleep-inducing peptide

Injection

What it is A 9-amino-acid peptide first discovered in Switzerland in 1977 in the blood of animals in deep (delta-wave) sleep.

How it works How it works is not fully understood. It appears to influence the brain’s sleep–wake signals and to help balance stress hormones such as cortisol.

Goals it may support Falling asleep and staying asleep, deeper and more restful sleep, and sleep thrown off by stress, shift work or travel.

What the evidence shows Small European studies in the 1980s and 1990s gave mixed results for insomnia.

How it is given A small injection under the skin in the evening, nightly or a few nights a week for a 1- to 2-week course.

Possible side effects Morning grogginess, headache or vivid dreams.

May not be right for you if You are pregnant or breastfeeding, or take sleep medicines or other sedatives.

  1. Clinical trialBes et al., Neuropsychobiology, 1992. In 16 adults with insomnia, slightly better sleep efficiency; authors judged effects weak. Netherlands.
  2. Human studySchneider-Helmert et al., Neuropsychobiology, 1983. Small studies suggest it may help normalize disturbed sleep. Switzerland.
  3. Human studyKaeser, European Neurology, 1984. In 7 patients with severe insomnia, sleep normalized in 6. Switzerland.
  4. Animal studyTukhovskaya et al., Molecules, 2021. Nasal DSIP improved movement recovery after stroke in rats. Russia.

Immune defense

LL-37A natural defense peptide made by your skin, gut and immune cells

Injection

What it is A 37-amino-acid peptide, also called cathelicidin, that your body makes as part of its first line of defense against germs.

How it works Lab studies show it can break apart the outer walls of bacteria and some viruses and fungi, and signal immune cells to respond and repair tissue.

Goals it may support Immune defense and healthy skin and gut barriers.

What the evidence shows Small trials suggest it may help chronic wounds heal when applied to the skin. Human data on injections are limited.

How it is given A small injection under the skin for a short course.

Possible side effects Redness, itching or soreness where injected.

May not be right for you if You are pregnant or breastfeeding, or have an autoimmune condition such as psoriasis or lupus.

  1. Clinical trialGrönberg et al., Wound Repair and Regeneration, 2014. LL-37 on hard-to-heal venous leg ulcers was safe and may have helped healing. Sweden.
  2. Clinical trialMiranda et al., Archives of Dermatological Research, 2023. LL-37 cream on infected diabetic foot ulcers sped new tissue formation. Indonesia.
  3. U.S. trial protocolAmaria (PI), ClinicalTrials.gov NCT02225366. MD Anderson phase 1/2 trial of LL-37 in melanoma. USA.
  4. ReviewDuplantier et al., Frontiers in Immunology, 2013. LL-37 for wound infections and bacterial films. USA (Virginia).

Metabolism and NAD+

5-Amino-1MQa small molecule (not a peptide) that blocks the NNMT enzyme

Oral capsule

What it is A small, drug-like molecule taken by mouth. It blocks NNMT, an enzyme found in high amounts in fat tissue that tends to rise with weight gain and aging.

How it works NNMT uses up some of the building blocks cells need to make NAD+. Blocking it may leave more NAD+ available, which in animal studies increased energy use in fat cells and shrank them. In older animals it also woke up muscle stem cells.

Goals it may support Fat metabolism, cellular energy and muscle recovery. It is sometimes paired with a GLP-1 medicine or NAD+.

What the evidence shows Research so far has been in animals and cells. It has not yet been tested in published human trials.

How it is given By mouth, usually once a day for a set course, alongside a nutrition and exercise plan.

Possible side effects Human side-effect data are limited, so we use it with close follow-up.

May not be right for you if You are pregnant, trying to conceive or breastfeeding.

  1. Animal studyKraus et al., Nature, 2014. Turning down the NNMT enzyme in mice protected them from diet-induced weight gain. USA.
  2. Animal studyNeelakantan et al., Biochemical Pharmacology, 2018. An NNMT blocker from the same family as 5-Amino-1MQ lowered body weight and fat mass in mice on a high-fat diet, without changing food intake. USA.
  3. Animal studyNeelakantan et al., Biochemical Pharmacology, 2019. In older mice, NNMT blocking activated muscle stem cells and improved muscle repair and strength after injury. USA.

About these therapies. The peptides and compounds in this section are not FDA-approved and are not among the six peptides covered by the federal policy announced in October 2026. They are prepared by compounding pharmacies for an individual patient on a prescription. The FDA has not reviewed them for safety, effectiveness or quality, and the FDA has raised safety concerns about some of them, including ipamorelin and kisspeptin. Evidence for many of these uses is limited, and some comes from studies outside the U.S. Federal rules on compounded peptides are changing, so availability may change. Dr. Verma will discuss the known risks and benefits with you before prescribing. Individual results vary and are not guaranteed.

Self-check

Which peptide goal fits you?

Choose your goals and we will show you which options may be worth discussing at your consultation.

1. What would you like help with?
2. Do any of these apply to you?

This self-check is for information only. It is not medical advice. Only a consultation can determine whether a peptide is right for you. Your answers stay on your device.

Peptides by goal

How peptides fit into your care

Weight and metabolism

GLP-1 medicines within our medical weight loss program, with MOTS-c as a possible add-on.

Hormone health

Sermorelin and Epitalon may complement hormone therapy for sleep, recovery and energy.

Sexual health

PT-141 and oxytocin as part of our men’s and women’s sexual health care.

Skin and hair

GHK-Cu with microneedling, the Vampire Facial® and PRP hair restoration.

Safety

Side effects and who should not use peptides

Possible side effects

Peptides may not be right for you if you

Common questions

Yes. As of October 2026, licensed U.S. compounding pharmacies can prepare BPC-157, TB-500, MOTS-c, Epitalon, Semax and KPV with a doctor’s prescription. Dr. Verma prescribes them after a consultation when they fit your goals and health history.

Ours are prepared by licensed U.S. pharmacies from ingredients tested for identity, purity and contaminants. Many online products are labeled “research only,” are not made for people, and may be mislabeled or contaminated.

No. Compounded medicines, including peptides, are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality. Some peptides, such as semaglutide and tirzepatide, are available as FDA-approved brand-name medicines.

Most are small injections under the skin that you learn to give at home, including BPC-157, TB-500, MOTS-c and Epitalon. Semax is a nasal spray or an injection, KPV is taken by mouth or as a cream, and some peptides come as a dissolving tablet.

It depends on the peptide and your goal. Recovery peptides are often used for several weeks. Epitalon is given in short courses once or twice a year. We review your progress and adjust.

Each peptide lists published studies so you can read the science for yourself. Many were done in animals or in small groups of people, often with different doses, forms or health conditions than in our practice. A study being listed does not mean it proves a peptide will work for you.

Often, yes. Labs help us choose safely and track your response.

Yes. Peptide therapy consultations are offered in Fairfax, as well as Warrenton and Culpeper.

No. Peptide therapy, including peptide consultations and follow-up visits, is self-pay and is not billed to insurance. We explain all costs at your consultation.

Important information. This page is for general education only. It is not medical advice and does not create a doctor–patient relationship. Peptides and the other therapies described here are prescribed only after a consultation, when Dr. Sagar Verma, MD, or another licensed provider decides they are appropriate for you. Compounded medicines, including compounded peptides, are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality. Many uses described on this page are off-label or still being studied, and much of the research comes from animal, lab or small human studies, some outside the U.S. Linked studies are provided for education and do not mean a treatment will work for you. Federal rules on compounded peptides are changing, so availability may change and this page may be updated. Possible side effects include injection-site reactions, nausea, flushing and headache. Individual results vary and are not guaranteed. In an emergency, call 911. Medical disclaimer.

Ready to talk to a doctor?

Choose a clinic and a time that suits you. New patients welcome.

SHE IS

Divine ♡

A day to reflect • recharge • rise

Let’s celebrate on Saturday, November 21, 2026 

11am to 2pm , in Warrenton, with mocktails, food, and guest speakers too.

First 10 registrants get a very special gift!

or call 540-680-2426

Book a consult Call us